DailyFinance http://www.dailyfinance.com DailyFinance http://www.blogsmithmedia.com/http://www.dailyfinance.com/media/feedlogo.gif DailyFinance http://www.dailyfinance.com en-us Copyright 2009 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/Philip Morris gets snuffed on a $300 million verdict for a former smokerhttp://www.dailyfinance.com/2009/11/20/philip-morris-gets-snuffed-on-a-300-million-verdict-for-a-forme/http://www.dailyfinance.com/2009/11/20/philip-morris-gets-snuffed-on-a-300-million-verdict-for-a-forme/http://www.dailyfinance.com/2009/11/20/philip-morris-gets-snuffed-on-a-300-million-verdict-for-a-forme/#commentsFiled under: ,

A Florida woman on Thursday won a $300 million judgment against Altria Group's (MO) unit Philip Morris USA -- the largest award yet among 8,000 lawsuits filed in the state against tobacco companies. Jurors took three hours to return the award to Cindy Naugle, 61, of Ft. Lauderdale, a former smoker who was given $56.6 million in compensatory damages and $244 million in punitive damages. Philip Morris is responsible for all of the punitive damages and for 90% of the compensatory ones. The jury found Naugle 10% at fault.

Naugle says she started smoking at 20 in 1968 and made repeated attempts to quit, finally succeeding in 1993. Today, she has emphysema, requires a 24-hour oxygen and must travel in a wheelchair.

Continue reading Philip Morris gets snuffed on a $300 million verdict for a former smoker

Philip Morris gets snuffed on a $300 million verdict for a former smoker originally appeared on DailyFinance on Fri, 20 Nov 2009 15:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>altrialawsuitphilip morrisPhilipMorrispunitivesuittobaccoverdictMelly AlazrakiFri, 20 Nov 2009 15:00:00 ESTStocks in the news: Dell, Goldman Sachs, D.R. Horton, J.M. Smuckerhttp://www.dailyfinance.com/2009/11/20/stocks-in-the-news-dell-goldman-sachs-d-r-horton-j-m-smuck/http://www.dailyfinance.com/2009/11/20/stocks-in-the-news-dell-goldman-sachs-d-r-horton-j-m-smuck/http://www.dailyfinance.com/2009/11/20/stocks-in-the-news-dell-goldman-sachs-d-r-horton-j-m-smuck/#commentsFiled under: , , , , , ,

Dell (DELL) reported results late Thursday, saying its net income dropped 54% in the latest quarter amid signs the company isn't fully benefiting from the computer industry's fledgling recovery. Dell's results missed Wall Street's estimates. Shares fell over 6.5% ahead of the bell.

Goldman Sachs Group's (GS) shareholders finally found a voice. Some of the largest shareholders have asked the company to cut the size of its bonus pool and pass along more of its profits to investors, The Wall Street Journal reported, citing people familiar with the situation.

Continue reading Stocks in the news: Dell, Goldman Sachs, D.R. Horton, J.M. Smucker

Stocks in the news: Dell, Goldman Sachs, D.R. Horton, J.M. Smucker originally appeared on DailyFinance on Fri, 20 Nov 2009 09:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiFri, 20 Nov 2009 09:00:00 ESTDell's disappointing earnings depress stock futureshttp://www.dailyfinance.com/2009/11/20/dells-disappointing-earnings-depress-stocks/http://www.dailyfinance.com/2009/11/20/dells-disappointing-earnings-depress-stocks/http://www.dailyfinance.com/2009/11/20/dells-disappointing-earnings-depress-stocks/#commentsFiled under: ,

U.S. stocks are set for yet another lower open Friday morning after two consecutive days of declines. The technology sector will remain in the spotlight after Dell's (DELL) worse-than-expected earnings reported late Thursday. As a whole, investors may be moving toward safer securities in the absence of confidence in the strength of the economic recovery.

Meanwhile, overseas, Asian markets finished lower and European shares erased their earlier gains after European Central Bank President Jean-Claude Trichet said the ECB will gradually withdraw emergency cash. Banks and energy stocks slipped.

More here: Before the bell: Futures lower on Dell's earnings, ECB move

Dell's disappointing earnings depress stock futures originally appeared on DailyFinance on Fri, 20 Nov 2009 08:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>DellearningsECBTrichetMelly AlazrakiFri, 20 Nov 2009 08:00:00 ESTAstraZeneca bets on a blood drug with multibillion-dollar potentialhttp://www.dailyfinance.com/2009/11/19/astrazeneca-bets-on-a-blood-drug-with-multibillion-dollar-potent/http://www.dailyfinance.com/2009/11/19/astrazeneca-bets-on-a-blood-drug-with-multibillion-dollar-potent/http://www.dailyfinance.com/2009/11/19/astrazeneca-bets-on-a-blood-drug-with-multibillion-dollar-potent/#commentsFiled under: , , , ,

AstraZeneca (AZN) has had a good week with its anticlotting drug Brilinta (ticagrelor). It impressed many observers by announcing positive results of a late-stage head-to-head study and a mid-stage study for Brilinta, and on Thursday, it said it had filed for Food and Drug Administration approval. Brilinta could be on the way to becoming a megablockbuster drug.

Study results for the experimental drug -- which fights acute coronary syndrome -- were first presented Sunday. For the study's 8,430 sickest patients, those taking the drug suffered fewer serious cardiovascular events (or deaths) than those taking Plavix, from Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY).

Continue reading AstraZeneca bets on a blood drug with multibillion-dollar potential

AstraZeneca bets on a blood drug with multibillion-dollar potential originally appeared on DailyFinance on Thu, 19 Nov 2009 16:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>anti-clottinganticlottingapprovalAstraZenecabloodbrilintabristol meyers squibbBristolMeyersSquibbclotdiabetesfdaglaxosmithklinelung cancerLungCanceronglyzaplavixSanofi-AventiszactimaMelly AlazrakiThu, 19 Nov 2009 16:00:00 ESTStocks in the news: Sears, JP Morgan, Intel, Hot Topichttp://www.dailyfinance.com/2009/11/19/stocks-in-the-news-sears-jp-morgan-intel-hot-topic/http://www.dailyfinance.com/2009/11/19/stocks-in-the-news-sears-jp-morgan-intel-hot-topic/http://www.dailyfinance.com/2009/11/19/stocks-in-the-news-sears-jp-morgan-intel-hot-topic/#commentsFiled under: , , , , , , ,

Sears Holding Corp. (SHLD) posted a smaller third-quarter loss Thursday of $127 million, or $1.09 per share, combating customers' continued desire to spend money elsewhere with tighter inventory management and cost-control efforts. Shares jumped 4% in pre-market trading. Excluding store closing costs and other items, Sears lost 81 cents per share, less than the average estimate of $1.09 loss per share.

J.P. Morgan (JPM) said Thursday that it will buy the half of the U.K. broker Cazenove it doesn't already own for around 1 billion pounds ($1.67 billion) in a deal that will net big payouts for many current and former employees. JPM shares dropped about 0.8% ahead of the bell.

Continue reading Stocks in the news: Sears, JP Morgan, Intel, Hot Topic

Stocks in the news: Sears, JP Morgan, Intel, Hot Topic originally appeared on DailyFinance on Thu, 19 Nov 2009 09:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiThu, 19 Nov 2009 09:10:00 ESTStocks ready to decline at the open on economic concernshttp://www.dailyfinance.com/2009/11/19/stocks-ready-to-decline-at-the-open-on-economic-concerns/http://www.dailyfinance.com/2009/11/19/stocks-ready-to-decline-at-the-open-on-economic-concerns/http://www.dailyfinance.com/2009/11/19/stocks-ready-to-decline-at-the-open-on-economic-concerns/#commentsFiled under: ,

U.S. stocks are poised for a lower start Thursday morning on economic concerns and the possibility that stocks may have run up too far, too fast ahead of the economy. The retail sector is in focus with several retailers reporting earnings. The tech sector may likely see continued pressure following a downgrade of microchips by Bank of America.

More here: Before the bell: Futures lower on economic conerns; retail, tech in focus

Stocks ready to decline at the open on economic concerns originally appeared on DailyFinance on Thu, 19 Nov 2009 07:45:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>retail earningsRetailEarningstech sectorTechSectorMelly AlazrakiThu, 19 Nov 2009 07:45:00 ESTGenzyme's bad year gets worse: Experimental kidney drug a no-gohttp://www.dailyfinance.com/2009/11/18/genzymes-bad-year-gets-worse-experimental-kidney-drug-a-no-go/http://www.dailyfinance.com/2009/11/18/genzymes-bad-year-gets-worse-experimental-kidney-drug-a-no-go/http://www.dailyfinance.com/2009/11/18/genzymes-bad-year-gets-worse-experimental-kidney-drug-a-no-go/#commentsFiled under: ,

genzymes-bad-year-gets-worse-experimental-kidney-drug-a-no-goFor Genzyme Corp (GENZ), this year seems to have been plagued with one piece of bad news after another. On Wednesday, the biotechnology company announced that it was dropping development of its experimental kidney disease drug after it failed to show significant improvement over the company's existing drug, Renvela.

Genzyme's first major setback this year came in the second quarter, when it had to temporarily shut down its Allston Landing, Mass., plant after viral contamination was discovered. The plant manufactures Cerezyme -- Genzyme's top-selling drug -- and Fabrazyme, a treatment for Fabry disease. Cerezyme treats Gaucher disease, a rare genetic disorder that can cause life-threatening organ damage, and the plant closure sparked fears of a shortage of the drug. The U.S. Food and Drug Administration consequently approved emergency use for two rival drugs from Protalix BioTherapeutics (PLX) and Shire (SHPGY).

Continue reading Genzyme's bad year gets worse: Experimental kidney drug a no-go

Genzyme's bad year gets worse: Experimental kidney drug a no-go originally appeared on DailyFinance on Wed, 18 Nov 2009 16:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>biotechcerezymeclolarcontaminationdrugFabrazymeFDAfood and drug administrationFoodAndDrugAdministrationGenzymekidneylumizymepharmapharmaceuticalPharmaceuticalsRenvelaTermeervirusMelly AlazrakiWed, 18 Nov 2009 16:00:00 ESTStocks in the news: Hershey, Goldman Sachs, Delta Air Lines, Chico'shttp://www.dailyfinance.com/2009/11/18/stocks-in-the-news-hershey-goldman-sachs-delta-air-lines-chi/http://www.dailyfinance.com/2009/11/18/stocks-in-the-news-hershey-goldman-sachs-delta-air-lines-chi/http://www.dailyfinance.com/2009/11/18/stocks-in-the-news-hershey-goldman-sachs-delta-air-lines-chi/#commentsFiled under: , , , , , , , , ,

Hershey Co. (HSY) and Italian chocolate maker Ferrero SpA said they're reviewing their options about making a joint bid for Cadbury Plc. (CBY) after it was approached by Kraft Foods Inc. (KFT). For their potential offer to succeed, it would have to be higher than Kraft's unsolicited offer of 10.3 billion pounds ($17 billion).

Goldman Sachs Group Inc. (GS) said it is launching a $500 million small-business assistance program that includes an advisory panel with billionaire investor Warren Buffett. On Tuesday, Goldman CEO Lloyd Blankfein apologized for his firm's role in the credit crisis.

Continue reading Stocks in the news: Hershey, Goldman Sachs, Delta Air Lines, Chico's

Stocks in the news: Hershey, Goldman Sachs, Delta Air Lines, Chico's originally appeared on DailyFinance on Wed, 18 Nov 2009 09:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiWed, 18 Nov 2009 09:20:00 ESTStocks set for lower open after housing, inflation datahttp://www.dailyfinance.com/2009/11/18/stocks-set-for-slightly-higher-open-ahead-of-housing-inflation/http://www.dailyfinance.com/2009/11/18/stocks-set-for-slightly-higher-open-ahead-of-housing-inflation/http://www.dailyfinance.com/2009/11/18/stocks-set-for-slightly-higher-open-ahead-of-housing-inflation/#commentsFiled under: ,

U.S. stocks are poised for a slightly higher open Wednesday morning after setting new 13-month highs Tuesday. Investors await key economic data this morning, including consumer prices and housing starts. As traders may step back this morning to assess the recent rally, the same trends that pushed markets higher on Tuesday remain: the dollar has dropped and commodities soared, driving mining stocks higher in overseas markets.

[Update 8:30 a.m.: October housing starts were down 30% from last year, the weakest they have been since April. The CPI rose 0.3% in October on higher energy, car prices. At first glance, these figures seem likely to affect the mood negatively. 8:35 a.m.: Stock market futures are declining, indicating a lower start.]

More here: Before the bell: Futures edge higher ahead of data

Stocks set for lower open after housing, inflation data originally appeared on DailyFinance on Wed, 18 Nov 2009 07:55:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiWed, 18 Nov 2009 07:55:00 ESTNew breast cancer screening guidelines confuse women as experts disagreehttp://www.dailyfinance.com/2009/11/17/new-breast-cancer-screening-guidelines-confuse-women-as-experts/http://www.dailyfinance.com/2009/11/17/new-breast-cancer-screening-guidelines-confuse-women-as-experts/http://www.dailyfinance.com/2009/11/17/new-breast-cancer-screening-guidelines-confuse-women-as-experts/#commentsFiled under:

new-breast-cancer-screening-guidelines-confuse-women-as-experts-disagreeIf the experts can't agree on guidelines for breast cancer screening, then how are women supposed to decide? At the end of the day, the new guidelines from the U.S. Preventive Services Task Force, a panel of independent experts, have left women quite confused. Several other expert sources, including the American Cancer Society, have criticized the new guidelines and disagree with them.

To recap, here are the new guidelines (which do not apply to higher-risk women):
  • Women between the ages of 40 and 49 should not be routinely screened.
  • Women between the ages of 50 and 74 should be screened every two years.
  • Screenings are unnecessary for women 75 and older.
  • Women should not be taught how to perform breast self-examinations.
  • There is no additional benefit to clinical breast examination by doctors, nor are there added benefits to digital mammography or magnetic resonance imaging over film mammography.

Continue reading New breast cancer screening guidelines confuse women as experts disagree

New breast cancer screening guidelines confuse women as experts disagree originally appeared on DailyFinance on Tue, 17 Nov 2009 16:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>American Cancer SocietyAmericanCancerSocietybreastbreast cancerBreastCancercancerfalse-positivesmammogrammammogramsmammographyoverdiagnosispreventive services task forcePreventiveServicesTaskForcescreeningself-examMelly AlazrakiTue, 17 Nov 2009 16:20:00 ESTSwine flu vaccine: U.S. wouldn't have a shortage if it embraced enhanced versionhttp://www.dailyfinance.com/2009/11/17/swine-flu-vaccine-u-s-wouldnt-have-a-shortage-if-it-embraced/http://www.dailyfinance.com/2009/11/17/swine-flu-vaccine-u-s-wouldnt-have-a-shortage-if-it-embraced/http://www.dailyfinance.com/2009/11/17/swine-flu-vaccine-u-s-wouldnt-have-a-shortage-if-it-embraced/#commentsFiled under: , ,

The majority of Americans want to be vaccinated against swine flu, polls show. But unless you're in a high-risk group, such as expectant mothers, you may not get any vaccine anytime soon. In fact, the Centers for Disease Control and Prevention says the current tide of H1N1 influenza is likely to begin to ebb before the shortage of vaccine eases. Meanwhile, the toll from the virus keeps climbing, with deaths from H1N1 in the United States having likely reached 4,000, of which 540 are children.

There are several reasons for the worrisome vaccine shortage. The federal government ordered enough vaccine to immunize nearly the entire nation. But deliveries have been slow, to name one big problem. Perhaps more frustrating to many on the front lines of fighting the virus is that the shortage would ease considerably if the U.S. simply embraced an enhanced version of the vaccine. But so far, U.S. regulatory authorities -- unlike their counterparts in Europe -- haven't taken the steps to make this happen.

Continue reading Swine flu vaccine: U.S. wouldn't have a shortage if it embraced enhanced version

Swine flu vaccine: U.S. wouldn't have a shortage if it embraced enhanced version originally appeared on DailyFinance on Tue, 17 Nov 2009 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>adjuvantadjuvanted vaccineAdjuvantedVaccineglaxosmithklineH1N1H1n1VirusIn FocusInFocusNovartisswine fluswine-fluSwineFluSwineFluPandemicMelly AlazrakiTue, 17 Nov 2009 10:00:00 ESTStocks in the news: Home Depot, Target, Exxon Mobilhttp://www.dailyfinance.com/2009/11/17/stocks-in-the-news-home-depot-target-berkshire-hathaway/http://www.dailyfinance.com/2009/11/17/stocks-in-the-news-home-depot-target-berkshire-hathaway/http://www.dailyfinance.com/2009/11/17/stocks-in-the-news-home-depot-target-berkshire-hathaway/#commentsFiled under: , , , , , , , , , , , ,

Home Depot (HD) said Tuesday that its third-quarter earnings fell 8.9% to $689 million, or 41 cents per share, as the housing and renovation markets remained weak. Revenue fell 8% to $16.36 billion. Same-store sales dropped 6.9%. Results beat estimates of 36 cents per share on revenue of $16.27 billion. The company also raised its full-year earnings outlook. Shares declined over 2% ahead of the bell.

Applied Materials Inc. (AMAT) said Tuesday that it will buy Semitool Inc. (SMTL) for $11 a share in an all-cash tender offer. The aggregate purchase price is about $364 million. Semitool shares, which closed Monday 10% higher at $8.4, shot up 30% in premarket trading to $10.94 at last check.

Lazard Ltd. (LAZ) announced Monday it has appointed Kenneth M. Jacobs, 51, as chairman of the board of directors and CEO, effective immediately. Jacobs replaces Bruce Wasserstein, who died on Oct. 14.

Continue reading Stocks in the news: Home Depot, Target, Exxon Mobil

Stocks in the news: Home Depot, Target, Exxon Mobil originally appeared on DailyFinance on Tue, 17 Nov 2009 09:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiTue, 17 Nov 2009 09:00:00 ESTStocks ready to retreat ahead of inflation datahttp://www.dailyfinance.com/2009/11/17/stocks-ready-to-retreat-ahead-of-inflation-data/http://www.dailyfinance.com/2009/11/17/stocks-ready-to-retreat-ahead-of-inflation-data/http://www.dailyfinance.com/2009/11/17/stocks-ready-to-retreat-ahead-of-inflation-data/#commentsFiled under: ,

U.S. stocks are poised for a lower start Tuesday morning following yet another strong rally on Monday. Several economic indicators will be in the spotlight today, including a key inflation gauge and a housing indicator. The housing market is further in focus with Home Depot's (HD) earnings release.

More here: Before the bell: Futures edge lower ahead of inflation data

Stocks ready to retreat ahead of inflation data originally appeared on DailyFinance on Tue, 17 Nov 2009 07:50:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiTue, 17 Nov 2009 07:50:00 ESTGlaxoSmithKline signs smoking vaccine licensing agreement with Nabihttp://www.dailyfinance.com/2009/11/16/glaxosmithkline-signs-smoking-vaccine-licensing-agreement-with-n/http://www.dailyfinance.com/2009/11/16/glaxosmithkline-signs-smoking-vaccine-licensing-agreement-with-n/http://www.dailyfinance.com/2009/11/16/glaxosmithkline-signs-smoking-vaccine-licensing-agreement-with-n/#commentsFiled under: ,

glaxosmithkline-signs-smoking-vaccine-licensing-agreement-with-nabiNot two months after the Swiss start-up Cytos's experimental anti-smoking vaccine failed in a mid-stage study, Nabi Biopharmaceuticals (NABI) and GlaxoSmithKline (GSK) have signed a licensing agreement for Nabi's own anti-smoking vaccine, NicVAX. The deal, which could potentially be worth more than half a billion dollars, helped push NABI shares 25% higher.

NicVAX is an experimental therapy for the treatment of nicotine addiction and the prevention of smoking relapse. The vaccine is designed to stimulate the immune system to produce antibodies that bind to the nicotine molecules. Once bound together, they are too large to cross the blood-brain barrier. In this way, the nicotine is blocked from reaching the receptors in the brain that cause the highly-addictive pleasure sensation experienced by smokers and users of nicotine products. When nicotine is prevented from supplying them the sensation they crave, smokers have an easier time kicking the habit.

Continue reading GlaxoSmithKline signs smoking vaccine licensing agreement with Nabi

GlaxoSmithKline signs smoking vaccine licensing agreement with Nabi originally appeared on DailyFinance on Mon, 16 Nov 2009 16:50:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>addictionagreementanti-smokingAntiSmokingclinicalclinical trialsClinicalTrialClinicalTrialslicensingnicotineNicotineAddictionNicVAXpleasuresmokingvaccineMelly AlazrakiMon, 16 Nov 2009 16:50:00 ESTStocks in the news: Lowe's, Cisco, General Electrichttp://www.dailyfinance.com/2009/11/16/stocks-in-the-news-lowes-cisco-general-electric/http://www.dailyfinance.com/2009/11/16/stocks-in-the-news-lowes-cisco-general-electric/http://www.dailyfinance.com/2009/11/16/stocks-in-the-news-lowes-cisco-general-electric/#commentsFiled under: ,

General Motors Co. reported a $1.2 billion loss Monday for the period since it left bankruptcy protection through Sept. 30, far better than previous quarters, and a sign that the auto giant is starting to turn around. GM also said it will begin repaying $6.7 billion in U.S. government loans with a $1.2 billion payment in December, and expects to repay the full amount by 2011.

Lowe's (LOW) said Monday its third-quarter profit fell 30% to $344 million, or 23 cents per share, as revenue declined 3% to $11.38 billion and same-store sales fell 7.5%. Customers continued to delay large purchases amid a weak economy, but Lowe's said some of the hardest-hit home markets are stabilizing. Excluding items, profit was 24 cents per share, inline with estimates.

Continue reading Stocks in the news: Lowe's, Cisco, General Electric

Stocks in the news: Lowe's, Cisco, General Electric originally appeared on DailyFinance on Mon, 16 Nov 2009 09:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiMon, 16 Nov 2009 09:00:00 ESTStocks ready for a strong start ahead of retail saleshttp://www.dailyfinance.com/2009/11/16/stocks-ready-for-a-strong-start-ahead-of-retail-sales/http://www.dailyfinance.com/2009/11/16/stocks-ready-for-a-strong-start-ahead-of-retail-sales/http://www.dailyfinance.com/2009/11/16/stocks-ready-for-a-strong-start-ahead-of-retail-sales/#commentsFiled under: ,

U.S. stocks are poised for a strong start Monday morning. Global stock markets got a boost after Japan's economy grew at faster-than-expected pace.

The economic plate is full this morning with retail sales and manufacturing data coming ahead of the opening bell and Federal Reserve Chairman Ben Bernanke speaking later in the day. GM's first earnings report is in focus this morning.

More here: Before the bell: Futures higher ahead of retail sales

Stocks ready for a strong start ahead of retail sales originally appeared on DailyFinance on Mon, 16 Nov 2009 08:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiMon, 16 Nov 2009 08:00:00 ESTStocks in the news: Walt Disney, J.C. Penney, Abercrombie & Fitchhttp://www.dailyfinance.com/2009/11/13/stocks-in-the-news-walt-disney-jc-penney-abercrombie-and-fitch/http://www.dailyfinance.com/2009/11/13/stocks-in-the-news-walt-disney-jc-penney-abercrombie-and-fitch/http://www.dailyfinance.com/2009/11/13/stocks-in-the-news-walt-disney-jc-penney-abercrombie-and-fitch/#commentsFiled under: , , , , , , , ,

Walt Disney Co. (DIS) reported late Thursday its fourth-quarter earnings grew 18% on improved results at cable network ESPN and syndication sales of "Grey's Anatomy" and "Desperate Housewives." The results were above estimates and showed improvement at the company's operations. Shares were 2.4% higher in pre-market trading.

J.C. Penney (JCP) reported Friday a lower quarterly profit of $27 million, or 11 cents a share, in line with estimates. Sales fell 3.2% to $4.18 billion in the third quarter. Same-store sales fell 4.6% during the quarter. But the retailer raised its forecast for the full year to a level that could top Wall Street expectations. Shares jumped nearly 5.5% ahead of the bell.

Continue reading Stocks in the news: Walt Disney, J.C. Penney, Abercrombie & Fitch

Stocks in the news: Walt Disney, J.C. Penney, Abercrombie & Fitch originally appeared on DailyFinance on Fri, 13 Nov 2009 09:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>DisneyDollar GeneralDollarGeneralipoJ.c.PenneyJcPenneyprofitquarterly earningsQuarterlyEarningsthird-quarterthird-quarter earningsThird-quarterEarningsMelly AlazrakiFri, 13 Nov 2009 09:10:00 ESTStocks ready to rebound after Disney's earnings, ahead of datahttp://www.dailyfinance.com/2009/11/13/stocks-ready-to-rebound-after-disneys-earnings-ahead-of-data/http://www.dailyfinance.com/2009/11/13/stocks-ready-to-rebound-after-disneys-earnings-ahead-of-data/http://www.dailyfinance.com/2009/11/13/stocks-ready-to-rebound-after-disneys-earnings-ahead-of-data/#commentsFiled under: ,

U.S. stocks are ready to rebound Friday morning. Investor sentiment got a boost from better-than-expected results at Walt Disney (DIS) and news that the eurozone has emerged from the recession. Still, this morning's economic releases, including trade balance and consumer sentiment, could change the tone.

More here: Before the bell: Stock futures higher ahead of consumer sentiment, trade gap data

Stocks ready to rebound after Disney's earnings, ahead of data originally appeared on DailyFinance on Fri, 13 Nov 2009 08:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiFri, 13 Nov 2009 08:10:00 ESTStocks in the news: Wal-Mart, Hewlett-Packard, 3Com, GE, United Techhttp://www.dailyfinance.com/2009/11/12/stocks-in-the-news-wal-mart-hewlett-packard-3com-ge-united/http://www.dailyfinance.com/2009/11/12/stocks-in-the-news-wal-mart-hewlett-packard-3com-ge-united/http://www.dailyfinance.com/2009/11/12/stocks-in-the-news-wal-mart-hewlett-packard-3com-ge-united/#commentsFiled under: ,

Wal-Mart Stores Inc. (WMT) reported a 3.2% increase in third-quarter profit, helped by inventory controls and other cost-cutting measures. Third-quarter profit was 84 cents a share, above Bloomberg's analyst estimates for profit of 81 cents. Wal-Mart also upped its full-year profit above estimates, but fourth-quarter guidance barely matched projections. Sales grew by just 1% while same-store sales fell by 0.4% in the quarter. Wal-Mart shares slid in pre-market trading.

Hewlett-Packard (HPQ) announced late Wednesday that it is acquiring networking company 3Com (COMS) for $2.7 billion. The $7.90 a share in cash 3Com shareholders will receive is at a 39% premium to Wednesday's closing price. The transaction is expected to close in the first half of 2010. 3Com shares soared over 33% in pre-market trading.

Continue reading Stocks in the news: Wal-Mart, Hewlett-Packard, 3Com, GE, United Tech

Stocks in the news: Wal-Mart, Hewlett-Packard, 3Com, GE, United Tech originally appeared on DailyFinance on Thu, 12 Nov 2009 09:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiThu, 12 Nov 2009 09:10:00 ESTStocks poised for a lower start after Wal-Mart's earningshttp://www.dailyfinance.com/2009/11/12/stocks-poised-for-a-lower-start-after-wal-marts-earnings/http://www.dailyfinance.com/2009/11/12/stocks-poised-for-a-lower-start-after-wal-marts-earnings/http://www.dailyfinance.com/2009/11/12/stocks-poised-for-a-lower-start-after-wal-marts-earnings/#commentsFiled under: , ,

U.S. stocks are poised to open Thursday's session on a down note a day after the Dow industrials hit yet another 13-month high, but the S&P 500 couldn't make it above the 1,100 level. Foreclosures continued to decline last month, but Wal-Mart's earnings and the expected weekly jobs data have dented sentiment further.

Wal-Mart Stores Inc. (WMT) posted third-quarter profit of 84 cents a share, above Bloomberg's analyst estimates for profit of 81 cents and it upped its full-year profit above estimates too. But as sales grew by just 1% in the quarter and fourth quarter guidance was weak, WMT shares slid over 1% in pre-market trading.

More here: Before the bell: Stocks to open lower despite Wal-mart's beat

Stocks poised for a lower start after Wal-Mart's earnings originally appeared on DailyFinance on Thu, 12 Nov 2009 08:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

]]>Melly AlazrakiThu, 12 Nov 2009 08:00:00 EST